RAVEN Biotechnologies' Series D Round

RAVEN Biotechnologies raised a round of funding on October 13, 2005.

Raven biotechnologies is a privately held biotechnology company focused on the simultaneous discovery of novel cell surface drug targets and the antibody therapeutics to regulate them. Raven's integra…

Articles about RAVEN Biotechnologies' Series D Round: